Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2267
https://www.valueinhealthjournal.com/article/S1098-3015(14)04197-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1727
First Page :
A633
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04197-7&doi=10.1016/j.jval.2014.08.2267